NurExone Biologic Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

nurexone.com

Country

Canada

Exchange

TSXV

Founded 2020

NurExone Biologic Inc., a pharmaceutical technology company develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. Founded in 2020, the company is based in Toronto, Canada.

Key Stats

52-Week Range

C$0.46C$1.14

Beta0.38

Trailing P/EN/A

Forward P/E-5.51

Trailing EPS-0.11

Avg Volume

Earnings & Analyst

Next Earnings2026-08-26

EPS Estimate-0.02

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.